1.
Wilson PM, Dixon S, Vell T, Bower P, Rootkin L, Williams C, Strong A, Lawrence D, Elvey R, Williams O, Stein N, Gibson JM. Implementation of inclisiran in UK primary care for patients with atherosclerotic cardiovascular disease (ASCVD) or ASCVD-risk equivalents: rationale and design of VICTORION-Spirit, a pragmatic phase IIIb, randomised controlled study. Int J Clin Trials [Internet]. 2023 Apr. 26 [cited 2025 Oct. 23];10(2):156-65. Available from: https://www.ijclinicaltrials.com/index.php/ijct/article/view/672